Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Hau

Showing results (121-130 of 180) with videos related to

Pageof 18
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|November 21, 2014
Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-L-tyrosine PETNorbert Galldiks, Veronika Dunkl, Gabriele Stoffels, et al.
Journal of Neuro-Oncology|June 15, 2022
Prognostic impact of obesity in newly-diagnosed glioblastoma: a secondary analysis of CeTeG/NOA-09 and GLARIUSJohannes Weller, Niklas Schäfer, Christina Schaub, et al.
Cell Cycle (Georgetown, Tex.)|May 11, 2016
Metformin inhibits proliferation and migration of glioblastoma cells independently of TGF-β2Corinna Seliger, Anne-Louise Meyer, Kathrin Renner, et al.
Neuro-Oncology Advances|August 19, 2024
Comprehensive multimodal deep learning survival prediction enabled by a transformer architecture: A multicenter study in glioblastomaAhmed Gomaa, Yixing Huang, Amr Hagag, et al.
BMC Cancer|September 4, 2009
RNOP-09: pegylated liposomal doxorubicine and prolonged temozolomide in addition to radiotherapy in newly diagnosed glioblastoma--a phase II studyChristoph P Beier, Christina Schmid, Thierry Gorlia, et al.
Cancers|June 10, 2022
Validation Study for Non-Invasive Prediction of <i>IDH</i> Mutation Status in Patients with Glioma Using In Vivo <sup>1</sup>H-Magnetic Resonance Spectroscopy and Machine LearningElisabeth Bumes, Claudia Fellner, Franz A Fellner, et al.
The New England Journal of Medicine|March 11, 2005
MGMT gene silencing and benefit from temozolomide in glioblastomaMonika E Hegi, Annie-Claire Diserens, Thierry Gorlia, et al.
Current Oncology (Toronto, Ont.)|October 25, 2024
Health-Related Quality of Life and Treatment Satisfaction of Patients with Malignant IDH Wild-Type Gliomas and Their CaregiversAnna Fischl, Michael Gerken, Patricia Lindberg-Scharf, et al.
Neuro-Oncology Practice|May 14, 2026
End-of-life challenges in neuro-oncological patient care: A survey from the Junge Neuroonkologische ArbeitsgemeinschaftLazaros Lazaridis, Niklas Benedikt Pepper, Paula Klein, et al.
Journal of Neuro-Oncology|October 22, 2008
Early relapses in primary CNS lymphoma after response to polychemotherapy without intraventricular treatment: results of a phase II studyHendrik Pels, Annika Juergens, Axel Glasmacher, et al.
Pageof 18

Showing results (121-130 of 180) with videos related to

Sort By:
Pageof 18
European Journal of Nuclear Medicine and Molecular Imaging|November 21, 2014
Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-L-tyrosine PETNorbert Galldiks, Veronika Dunkl, Gabriele Stoffels, et al.
Journal of Neuro-Oncology|June 15, 2022
Prognostic impact of obesity in newly-diagnosed glioblastoma: a secondary analysis of CeTeG/NOA-09 and GLARIUSJohannes Weller, Niklas Schäfer, Christina Schaub, et al.
Cell Cycle (Georgetown, Tex.)|May 11, 2016
Metformin inhibits proliferation and migration of glioblastoma cells independently of TGF-β2Corinna Seliger, Anne-Louise Meyer, Kathrin Renner, et al.
Neuro-Oncology Advances|August 19, 2024
Comprehensive multimodal deep learning survival prediction enabled by a transformer architecture: A multicenter study in glioblastomaAhmed Gomaa, Yixing Huang, Amr Hagag, et al.
BMC Cancer|September 4, 2009
RNOP-09: pegylated liposomal doxorubicine and prolonged temozolomide in addition to radiotherapy in newly diagnosed glioblastoma--a phase II studyChristoph P Beier, Christina Schmid, Thierry Gorlia, et al.
Cancers|June 10, 2022
Validation Study for Non-Invasive Prediction of <i>IDH</i> Mutation Status in Patients with Glioma Using In Vivo <sup>1</sup>H-Magnetic Resonance Spectroscopy and Machine LearningElisabeth Bumes, Claudia Fellner, Franz A Fellner, et al.
The New England Journal of Medicine|March 11, 2005
MGMT gene silencing and benefit from temozolomide in glioblastomaMonika E Hegi, Annie-Claire Diserens, Thierry Gorlia, et al.
Current Oncology (Toronto, Ont.)|October 25, 2024
Health-Related Quality of Life and Treatment Satisfaction of Patients with Malignant IDH Wild-Type Gliomas and Their CaregiversAnna Fischl, Michael Gerken, Patricia Lindberg-Scharf, et al.
Neuro-Oncology Practice|May 14, 2026
End-of-life challenges in neuro-oncological patient care: A survey from the Junge Neuroonkologische ArbeitsgemeinschaftLazaros Lazaridis, Niklas Benedikt Pepper, Paula Klein, et al.
Journal of Neuro-Oncology|October 22, 2008
Early relapses in primary CNS lymphoma after response to polychemotherapy without intraventricular treatment: results of a phase II studyHendrik Pels, Annika Juergens, Axel Glasmacher, et al.
Pageof 18